Activation of cyclin D1-kinase in murine fibroblasts lacking both p21(Cip1) and p27(Kip1)
- PMID: 12444543
- DOI: 10.1038/sj.onc.1206019
Activation of cyclin D1-kinase in murine fibroblasts lacking both p21(Cip1) and p27(Kip1)
Abstract
Deregulation of D-type cyclin-dependent kinases (CDK4 and 6) is widely observed in various human cancers, illustrating their importance in cell cycle control. Like other cyclin-dependent kinases (CDKs), assembly with cyclins is the most critical step for activation of CDK4/6. As previously reported elsewhere, we observed that the level of cyclinD1-CDK4 complex and its associated kinase activity were significantly low in asynchronously proliferating mouse embryo fibroblasts lacking both p21(Cip1) and p27(Kip1) (p21/p27-null MEFs). These evidences imply that p21(Cip1) and p27(Kip1) CDK inhibitors are 'essential activators' of cyclin D-kinases. We, however, discovered here that both the assembly and activation of cyclin D1-CDK4 complex occur when quiescent p21/p27-null MEFs were stimulated to re-enter the cell cycle. This mitogen-induced cyclin D1-kinase activity was blocked by overexpression of p16(INK4a) and resulted in the inhibition of S phase entry in p21/p27-null MEFs. Furthermore, ectopic expression of p34(SEI-1), a mitogen-induced CDK4 binding protein, increased the levels of active cyclinD1-CDK4 complex in asynchronously proliferating p21/p27-null MEFs. Together, our results suggest that there are several independent ways to stimulate the assembly of cyclin D1-CDK4 kinases. Although p21(Cip1) and p27(Kip1) play a role in this process, our results demonstrate that additional mechanisms must occur in G0 to S phase transition.
Similar articles
-
P27Kip1 and p21Cip1 are not required for the formation of active D cyclin-cdk4 complexes.Mol Cell Biol. 2003 Oct;23(20):7285-90. doi: 10.1128/MCB.23.20.7285-7290.2003. Mol Cell Biol. 2003. PMID: 14517297 Free PMC article.
-
Cell cycle exit during terminal erythroid differentiation is associated with accumulation of p27(Kip1) and inactivation of cdk2 kinase.Blood. 2000 Oct 15;96(8):2746-54. Blood. 2000. PMID: 11023508
-
Analysis of cyclin D3-cdk4 complexes in fibroblasts expressing and lacking p27(kip1) and p21(cip1).Mol Cell Biol. 2000 Dec;20(23):8748-57. doi: 10.1128/MCB.20.23.8748-8757.2000. Mol Cell Biol. 2000. PMID: 11073976 Free PMC article.
-
Aberrant cell cycle regulation in cervical carcinoma.Yonsei Med J. 2005 Oct 31;46(5):597-613. doi: 10.3349/ymj.2005.46.5.597. Yonsei Med J. 2005. PMID: 16259056 Free PMC article. Review.
-
Cyclins and CDKS in development and cancer: lessons from genetically modified mice.Front Biosci. 2006 Jan 1;11:1164-88. doi: 10.2741/1871. Front Biosci. 2006. PMID: 16146805 Review.
Cited by
-
Competing memories of mitogen and p53 signalling control cell-cycle entry.Nature. 2017 Sep 21;549(7672):404-408. doi: 10.1038/nature23880. Epub 2017 Sep 6. Nature. 2017. PMID: 28869970 Free PMC article.
-
Genetic characterization of the role of the Cip/Kip family of proteins as cyclin-dependent kinase inhibitors and assembly factors.Mol Cell Biol. 2014 Apr;34(8):1452-9. doi: 10.1128/MCB.01163-13. Epub 2014 Feb 10. Mol Cell Biol. 2014. PMID: 24515438 Free PMC article.
-
CDK6-a review of the past and a glimpse into the future: from cell-cycle control to transcriptional regulation.Oncogene. 2016 Jun 16;35(24):3083-91. doi: 10.1038/onc.2015.407. Epub 2015 Oct 26. Oncogene. 2016. PMID: 26500059 Review.
-
CDK4: A Key Player in the Cell Cycle, Development, and Cancer.Genes Cancer. 2012 Nov;3(11-12):658-69. doi: 10.1177/1947601913478972. Genes Cancer. 2012. PMID: 23634254 Free PMC article.
-
Cyclin-dependent kinase inhibitors in malignant hematopoiesis.Front Oncol. 2022 Aug 11;12:916682. doi: 10.3389/fonc.2022.916682. eCollection 2022. Front Oncol. 2022. PMID: 36033505 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
Miscellaneous